Comment on: Revised ISHAM-ABPA working group clinical practice guidelines for diagnosing, classifying and treating allergic bronchopulmonary aspergillosis/mycoses
Summary
No summary yet. VIRAT can read this paper and write a plain-language summary of its aim, methods, key findings and limitations.
Summarise with VIRAT Free to try with your Science Catalogs account.Abstract
Extract We read with great interest the diagnostic criteria for allergic bronchopulmonary aspergillosis/mycoses (ABPA/M) proposed by the International Society for Human and Animal Mycology (ISHAM) working group [1], that was recently published in the European Respiratory Journal. Agarwal et al. [2] reported that Aspergillus fumigatus sensitisation affects up to 25% of adult asthmatic patients presenting to tertiary care centres, with nearly 37% of sensitised individuals progressing to ABPA.
Fields of Study & Subjects
Asthma and respiratory diseases
Antifungal resistance and susceptibility
Cystic Fibrosis Research Advances
Publication details
- Journal / source
- European Respiratory Journal
- Volume
- 67
- Issue
- 4
- Pages
- 2501724–2501724
- Publication date
- 1 April 2026
- Language
- EN